Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease (Q35161561)

6 August 2017

title

Influence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

6 August 2017

main subject

1 reference

Yu Nishijima

1

1 reference

6 August 2017

Seigo Minami

2

1 reference

6 August 2017

Suguru Yamamoto

3

1 reference

6 August 2017

Yoshitaka Ogata

4

1 reference

6 August 2017

Taro Koba

5

1 reference

6 August 2017

Shinji Futami

6

1 reference

6 August 2017

Kiyoshi Komuta

7

1 reference

6 August 2017

language of work or name

English

0 references

publication date

27 February 2015

1 reference

International Journal of Chronic Obstructive Pulmonary Disease

6 August 2017

published in

1 reference

6 August 2017

volume

10

1 reference

6 August 2017

page(s)

439-444

1 reference

Creative Commons Attribution-NonCommercial 3.0 Unported

6 August 2017

copyright license

start time

1 February 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Indacaterol improves daily physical activity in patients with chronic obstructive pulmonary disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Assessing efficacy of indacaterol in moderate and severe COPD patients: a 12-week study in an Asian population

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Standardisation of spirometry

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

The 6-min walk distance: change over time and value as a predictor of survival in severe COPD.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Reduced level of physical activity in Japanese patients with chronic obstructive pulmonary disease.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Development of the Japanese version of the COPD Assessment Test

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Validation of a Compact Motion Sensor for the Measurement of Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Development and first validation of the COPD Assessment Test

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

The use of uniaxial accelerometry for the assessment of physical-activity-related energy expenditure: a validation study against whole-body indirect calorimetry

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan

27 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4354394

Quantitating physical activity in COPD using a triaxial accelerometer

27 September 2018

1 reference

12 December 2020

How many days of pedometer monitoring predict weekly physical activity in adults?

1 reference

12 December 2020

Once-daily indacaterol versus twice-daily salmeterol for COPD: a placebo-controlled comparison

1 reference

12 December 2020

Effect of indacaterol on exercise endurance and lung hyperinflation in COPD

1 reference

12 December 2020

Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study

1 reference

12 December 2020

Effect of Indacaterol on Dynamic Lung Hyperinflation and Breathlessness in Hyperinflated Patients with COPD

1 reference

12 December 2020

Efficacy and safety of indacaterol 150 and 300 µg in chronic obstructive pulmonary disease patients from six Asian areas including Japan: A 12‐week, placebo‐controlled study

1 reference

12 December 2020

Identifiers

DOI

10.2147/COPD.S76836

1 reference

6 August 2017

1 reference

6 August 2017

1 reference